Skip to main content
SpringerLink
Log in

The New Attitude of the European Regulatory Authorities About Herbal Medicinal Products

  • Published:
Drug information journal : DIJ / Drug Information Association Aims and scope Submit manuscript

Abstract

In 1997, an ad hoc Herbal Medicinal Products Working Group (HMPWG) was established at the European Medicines Evaluation Agency in order to provide guidance for applicants and prepare recommendations on the criteria for the assessment of quality, safety, and efficacy of herbal medicinal products. The following topics were addressed in a detailed document containing several notes for guidance, comments, or points to consider: Notice to Applicants (presentation and content of the application dossier), quality guidance (agricultural production, requirements of active herbal substances and herbal medicinal products, and Type I and Type II variations), and preclinical and clinical assessment (giving particular emphasis to taking the existing scientific literature into account in order to avoid unnecessary animal tests and clinical trials in humans). Details and implications of these documents are presented here.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Law J. Making sense of herbal medicines. Scrip Magazine. May 1999;37–39.

    Google Scholar 

  2. Biffignandi P. Nutraceuticals and functional foods: a consumer-driven regulatory issue. ESRA Rapporteur. 1999;6(5):24–27.

    Google Scholar 

  3. Bloch A, Thomson CA. Position of the American Dietetic Association: Phytochemicals and functional foods. J Nutraceuticals, Functional Med Foods. 1997;1:33–45.

    Article  Google Scholar 

  4. Dichek B. Enhancing the effects of nutraceuticals. Scrip Magazine, May 1999, p. 35.

    Google Scholar 

  5. Steinhoff B. The contribution of the European Scientific Cooperative on Phytotherapy and World Health Organization monographs. Drug Inf J. 1999;33:17–22.

    Article  Google Scholar 

  6. FDA. Guidance for Industry: Providing Clinical Evidence of Effectiveness for Human Drugs and Biological Products. Rockville, MD: Food and Drug Administration; May 1998.

    Google Scholar 

  7. Artiges A. Pharmacopoeial standards for herbal medicinal products in Europe. European Phytojournal. 1999. (www.ex.ac.uk/phytonet/phytojournal/)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Società Italiana Attività Farmaceutiche, Corso Re Umberto I, 44, 10128, Torino, Italy

    Paolo M. Biffignandi MD, PhD

  2. VI.REL Pharma, Vinovo (Torino), Italy

    Lorella Carletto PhD

Authors
  1. Paolo M. Biffignandi MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lorella Carletto PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Biffignandi, P.M., Carletto, L. The New Attitude of the European Regulatory Authorities About Herbal Medicinal Products. Ther Innov Regul Sci 34, 801–808 (2000). https://doi.org/10.1177/009286150003400316

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1177/009286150003400316

Key Words

Search

Navigation